Edwards Lifesciences Corporation (EW) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Devices industria. La empresa tiene su sede en Irvine, CA, United States. El CEO actual es Bernard J. Zovighian.
EW tiene fecha de IPO 2000-03-27, 15,800 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $45.42B.
Edwards Lifesciences Corporation is a global medical device company headquartered in Irvine, California, specializing in structural heart disease treatment and critical care monitoring solutions. The company develops and markets minimally invasive transcatheter heart valve replacement and repair products, including the PASCAL and Cardioband systems for treating mitral and tricuspid valve diseases, as well as surgical structural heart solutions such as the INSPIRIS aortic valve and HARPOON Beating Heart Mitral Valve Repair System. Additionally, Edwards Lifesciences provides advanced hemodynamic monitoring systems and predictive software solutions for intensive care settings to help clinicians manage patient heart function and prevent critical complications. Operating since 1958, the company serves markets across the United States, Europe, Japan, and internationally through both direct sales and independent distributors.
